Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)
Crossref DOI link: https://doi.org/10.1186/s12931-015-0250-2
Published Online: 2015-08-02
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bateman, Eric D.
Chapman, Kenneth R.
Singh, Dave
D’Urzo, Anthony D.
Molins, Eduard
Leselbaum, Anne
Gil, Esther Garcia